Design Therapeutics, Inc. 8-K

What Happened
Design Therapeutics, Inc. announced its financial results for the three and twelve months ended December 31, 2025 via a press release dated March 9, 2026. The company furnished the press release as Exhibit 99.1 to an 8-K (Item 2.02); the filing was signed by President, CEO and Chairperson Pratik Shah, Ph.D. The company noted the information is being furnished (not “filed”) under the Exchange Act.

Key Details

• Filing date: March 9, 2026 (Form 8-K, Item 2.02).
• Reporting period: three months and twelve months ended December 31, 2025.
• Exhibit: Press release attached as Exhibit 99.1.
• Signed by: Pratik Shah, Ph.D., President, Chief Executive Officer and Chairperson.

Why It Matters
The press release contains the company's quarterly and full-year financial results—key data for evaluating recent revenue, expenses, cash position and operating performance. Investors should review Exhibit 99.1 for the specific numbers, any management commentary, and implications for near-term outlook or liquidity. Note that because the release is furnished (not filed), it is not subject to Section 18 liability and is not automatically incorporated by reference into other SEC filings.